QNRX - Quoin Pharmaceuticals GAAP EPS of -$3.24 August, 18 2022 07:08 AM Quoin Pharmaceuticals Ltd. Quoin Pharmaceuticals press release ( NASDAQ: QNRX ): Q2 GAAP EPS of -$3.24. Quoin ended the second quarter with approximately $2.7 million in cash. Shares -5% PM. For further details see: Quoin Pharmaceuticals GAAP EPS of -$3.24